Company / Interest Expense
Arcadia Biosciences, Inc. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$782.0K
FY2025
5-year range
-$20.0K / $782.0K
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has increased for 3 consecutive years, from -$20,000 in FY2022 to $782,000 in FY2025.
Based on SEC 10-K filings.
$782,000 in FY2025 with a 5-year CAGR of +174.7%.
Increased from $289,000 to $782,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +174.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s interest expense has grown for 3 consecutive years.
- 5-year CAGR of +174.7%, indicating consistent growth.
- In FY2025, interest expense increased 12.5% year-over-year.
- Peak interest expense was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $782.0K | +12.5% |
| FY2024 | $695.0K | +140.5% |
| FY2023 | $289.0K | +1545.0% |
| FY2022 | -$20.0K | -142.6% |
| FY2021 | $47.0K | +840.0% |
| FY2020 | $5.0K | +0.0% |
| FY2019 | $5.0K | -99.3% |
| FY2018 | $747.0K | -43.4% |
| FY2017 | $1.3M | -50.4% |
| FY2016 | $2.7M | +90.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026